SCHEMBL19494919

SCHEMBL19494919

CC(C)[S+]([O-])c1cc(C(N)=O)c(NC(=O)c2ccccc2O)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.43
▸ MAPT P10636 2/20 0.43
▸ CFTR P13569 3/20 0.42
▸ HSD17B10 Q99714 6/20 0.41
▸ HPGD P15428 4/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ LMNA P02545 6/20 0.40
▸ HTT P42858 4/20 0.40
▸ TP53 P04637 3/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494649 0.88 CFTR (0.43) KDM4EMAPTCFTRHSD17B10HPGD
SCHEMBL19494912 0.78 CFTR (0.40) KDM4EMAPTCFTRHSD17B10HPGD
SCHEMBL16246225 0.75 CFTR (0.45) KDM4EMAPTCFTRHSD17B10HPGD
SCHEMBL2699680 0.75 STAT3 (0.57) KDM4EMAPTHSD17B10HPGDALDH1A1
SCHEMBL16246469 0.75 CFTR (0.44) KDM4EMAPTCFTRHSD17B10HPGD
SCHEMBL16263896 0.71 FLT3 (0.44) KDM4EMAPTHSD17B10HPGDALDH1A1
SCHEMBL16338522 0.70 CFTR (0.65) KDM4EMAPTCFTRMEN1KMT2A
SCHEMBL6999862 0.68 JAK2 (0.64) IKBKBJAK2JAK3
SCHEMBL2698761 0.68 NPC1 (0.62) KDM4EMAPTHSD17B10HPGDALDH1A1
SCHEMBL19494315 0.68 NPC1 (0.43) KDM4EMAPTHSD17B10HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback